SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care (POC) rapid diagnostic tests, today announced recent initiatives to educate and inform the healthcare community ...

The COVID-19 pandemic has enabled consumers to perform rapid self-tests in the comfort of their homes, a convenient option that test makers like Abbott Laboratories, Becton Dickinson and Quidel are ...

After a blockbuster two years bolstered by sales of its multiple COVID-19 diagnostics, Quidel is looking for a way to reinvest that windfall back into the business—and seems to have found it in the ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

A couple of months back we discussed that Quidel stock may see lower levels, based on the Trefis machine learning engine, which analyzes historical stock price movements. QDEL stock is now down 14% ...

Summer is time for camp—but it's also prime season for Lyme disease. That's the reminder from diagnostic maker Quidel, which has launched an awareness campaign highlighting the rise and risk of the ...

Diagnostic test maker Quidel saw revenue surge in the third quarter, driven by demand for its rapid COVID-19 tests amid the Delta variant spike in cases this summer. The San Diego company — which ...

Forbes contributors publish independent expert analyses and insights. Quidel, a company that makes diagnostic products for infectious diseases and other conditions, has been the biggest winner in our ...

When determining winners and losers in the 2020-2021 stock market, it is important not to overlook the companies that supply testing kits for COVID-19. The Quidel Corporation (QDEL) manufactures rapid ...

Quidel is a highly profitable medical diagnostic company. It has now diversified into Covid testing. The company has both the scale and financial capacity to take on the challenge to produce high ...

Quidel is recalling its Lyra COVID-19 test because of a “significant” risk of false negative results in people infected with high amounts of the virus, the FDA said July 7. The test, which was granted ...